共 50 条
- [50] Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study JOURNAL OF CROHNS & COLITIS, 2022, 16 : I537 - I537